0000899243-20-032813.txt : 20201204 0000899243-20-032813.hdr.sgml : 20201204 20201204212809 ACCESSION NUMBER: 0000899243-20-032813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201123 FILED AS OF DATE: 20201204 DATE AS OF CHANGE: 20201204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BLUTT MITCHELL J MD CENTRAL INDEX KEY: 0001097955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 201371201 MAIL ADDRESS: STREET 1: 1370 AVENUE OF THE AMERICA STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Consonance Capital Management LP CENTRAL INDEX KEY: 0001544773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 201371202 BUSINESS ADDRESS: STREET 1: 1370 AVENUE OF THE AMERICAS STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.660-8062 MAIL ADDRESS: STREET 1: 1370 AVENUE OF THE AMERICAS STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Consonance Capital Opportunity Fund Management LP CENTRAL INDEX KEY: 0001834998 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 201371203 BUSINESS ADDRESS: STREET 1: 1370 AVENUE OF THE AMERICAS STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-660-8078 MAIL ADDRESS: STREET 1: 1370 AVENUE OF THE AMERICAS STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Consonance Capman GP, LLC CENTRAL INDEX KEY: 0001620428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 201371204 BUSINESS ADDRESS: STREET 1: 1370 AVENUE OF AMERICA STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.660.8077 MAIL ADDRESS: STREET 1: 1370 AVENUE OF AMERICA STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Consonance-HFW Acquisition Corp. CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981556622 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 921-2333 MAIL ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-23 0 0001824893 Consonance-HFW Acquisition Corp. CHFW 0001097955 BLUTT MITCHELL J MD 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 1 0 1 0 0001544773 Consonance Capital Management LP 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 1 0 1 0 0001834998 Consonance Capital Opportunity Fund Management LP 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 1 0 1 0 0001620428 Consonance Capman GP, LLC 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 1 0 1 0 Class A Ordinary Shares 2020-11-23 4 P 0 500000 A 500000 I By Consonance Capital Master Account, LP Class A Ordinary Shares 2020-11-23 4 P 0 371100 A 371100 I By Consonance Capital Opportunity Master Fund, LP Class A Ordinary Shares 2020-11-23 4 P 0 128900 A 128900 I By Managed Account Class A Ordinary Shares 434000 I By Consonance Life Sciences, LLC Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. Consonance Capital Management LP ("Consonance Management") is an indirect beneficial owner of the Class A Shares held by Consonance Capital Master Account, LP (the "Master Account"). Consonance Management is the investment adviser of the Master Account, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by the Master Account. Consonance Capman GP LLC ("Capman") is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation. (Continued from footnote 2) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. Consonance Management is an indirect beneficial owner of the Class A Shares held by Consonance Capital Opportunity Master Fund, LP ("Consonance Opportunity Master"). Consonance Management is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by Consonance Opportunity Master. Capman is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by Consonance Opportunity Master as the manager and member of the general partner of Consonance Opportunity Master and thereby is entitled to a portion of the profits allocation. (Continued from footnote 4) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. Consonance Capital Opportunity Fund Management LP ("Consonance Opportunity") is an indirect beneficial owner of the Class A Shares held by a certain managed account (the "Managed Account"). Consonance Opportunity is the investment adviser of the Managed Account and exercises voting and investment power over the securities of the Issuer held by the Managed Account. Capman is the general partner of Consonance Opportunity. Consonance Opportunity receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman. Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. Consonance Life Sciences, LLC ("Consonance Life Sciences") is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein. The Master Fund, Consonance Opportunity Master and the Managed Account in the aggregate own the majority of the unit interests in Consonance Life Sciences. Consonance Capman GP LLC ("Capman") is the general partner of Consonance Capital Management LP ("Consonance Management") and Consonance Capital Opportunity Fund Management LP ("Consonance Opportunity"). Mitchell Blutt is the manager and member of Capman. Consonance Life Sciences, LLC ("Consonance Life Sciences") is governed by a board of managers consisting of Mitchell Blutt, Benny Soffer and Kevin Livingston. Dr. Blutt is the Chairman of the Board of Directors (the "Board") of Consonance-HFW Acquisition Corp. (the "Issuer"). In addition, Benny Soffer, a Partner at Consonance Management, is a member of the Issuer's Board. By virtue of their representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Consonance Management, Consonance Opportunity, Capman, Consonance Life Sciences and certain of their affiliates, including the Consonance Capital Master Account, LP, Consonance Capital Opportunity Master Fund, LP and a certain managed account, are deemed directors by deputization of the Issuer. CONSONANCE CAPITAL MANAGEMENT LP, By: Consonance Capman GP LLC, its general partner, Name: /s/ Mitchell J. Blutt, M.D., Title: Manager and Member 2020-12-04 CONSONANCE CAPITAL OPPORTUNITY FUND MANAGEMENT LP, By: Consonance Capman GP LLC, its general partner, Name: /s/ Mitchell J. Blutt, M.D., Title: Manager and Member 2020-12-04 CONSONANCE CAPMAN GP LLC, Name: /s/ Mitchell J. Blutt, M.D., Title: Manager and Member 2020-12-04 MITCHELL J. BLUTT, Name: /s/ Mitchell J. Blutt, M.D. 2020-12-04 EX-99.1 2 attachment1.htm EX-99.1 DOCUMENT

                                                                    Exhibit 99.1

                         Form 4 Joint Filer Information

Name:                                   Consonance Capital Management LP

Address:                                1370 Avenue of the Americas
                                        Suite 3301
                                        New York, NY 10019

Date of Event Requiring Statement:      11/23/2020



Name:                                   Consonance Capital Opportunity Fund
                                        Management LP

Address:                                1370 Avenue of the Americas
                                        Suite 3301
                                        New York, NY 10019

Date of Event Requiring Statement:      11/23/2020



Name:                                   Consonance Capman GP LLC

Address:                                1370 Avenue of the Americas
                                        Suite 3301
                                        New York, NY 10019

Date of Event Requiring Statement:      11/23/2020